|
6962
|
metaproterenol sulf
|
Boehringer Ingelheim Corporation
|
6505-01-203-3389 |
Avl
|
RFQ
|
|
CATAPRES 0 2 MG
|
clonidine hydrochlo
|
Boehringer Ingelheim Corporation
|
6505-01-005-8425 |
Avl
|
RFQ
|
|
3112
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3319 |
Avl
|
RFQ
|
|
NDC00597-0007-01
|
clonidine hydrochlo
|
Boehringer Ingelheim Corporation
|
6505-01-005-8425 |
Avl
|
RFQ
|
|
CATAPRES TTS 3
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3318 |
Avl
|
RFQ
|
|
CATAPRES TTS 1
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3319 |
Avl
|
RFQ
|
|
NDC00597 0048 01
|
theophylline extend
|
Boehringer Ingelheim Corporation
|
6505-01-094-1613 |
Avl
|
RFQ
|
|
NDC00597-0019-61
|
dipyridamole tablets usp
|
Boehringer Ingelheim Corporation
|
6505-01-189-7085 |
Avl
|
RFQ
|
|
NDC00597 0021 01
|
mesoridazine besyla
|
Boehringer Ingelheim Corporation
|
6505-00-137-7745 |
Avl
|
RFQ
|
|
NDC00597-0020-01
|
mesoridazine besyla
|
Boehringer Ingelheim Corporation
|
6505-00-138-7980 |
Avl
|
RFQ
|
|
NDC00597-0027-02
|
mesoridazine besyla
|
Boehringer Ingelheim Corporation
|
6505-00-159-8115 |
Avl
|
RFQ
|
|
NDC00597-0086-76
|
ipratropium bromide nasal solution
|
Boehringer Ingelheim Corporation
|
6505-01-430-8710 |
Avl
|
RFQ
|
|
NDC00597-0017-90
|
dipyridamole tablet
|
Boehringer Ingelheim Corporation
|
6505-01-109-9469 |
Avl
|
RFQ
|
|
NDC00597-0087-17
|
ipratropium bromide
|
Boehringer Ingelheim Corporation
|
6505-01-536-9470 |
Avl
|
RFQ
|
|
NDC00597 0066 61
|
mexiletine hydrochl
|
Boehringer Ingelheim Corporation
|
6505-01-255-9027 |
Avl
|
RFQ
|
|
NDC00597-0073-16
|
metaproterenol sulf
|
Boehringer Ingelheim Corporation
|
6505-01-078-0667 |
Avl
|
RFQ
|
|
NDC00597-0019-61
|
dipyridamole tablet
|
Boehringer Ingelheim Corporation
|
6505-01-150-1476 |
Avl
|
RFQ
|
|
NDC00597 0033 34
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3318 |
Avl
|
RFQ
|
|
2702
|
mesoridazine besyla
|
Boehringer Ingelheim Corporation
|
6505-00-159-8115 |
Avl
|
RFQ
|
|
597 0070 86
|
metaproterenol sulf
|
Boehringer Ingelheim Corporation
|
6505-01-051-6464 |
Avl
|
RFQ
|
|
NDC00597-0012-01
|
bisacodyl delayed r
|
Boehringer Ingelheim Corporation
|
6505-00-890-1189 |
Avl
|
RFQ
|
|
CATAPRES TTS 2
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3317 |
Avl
|
RFQ
|
|
NDC00597 0018 10
|
dipyridamole tablet
|
Boehringer Ingelheim Corporation
|
6505-01-147-2475 |
Avl
|
RFQ
|
|
6861
|
mexiletine hydrochl
|
Boehringer Ingelheim Corporation
|
6505-01-255-9031 |
Avl
|
RFQ
|
|
NDC00597 0006 61
|
clonidine hydrochlo
|
Boehringer Ingelheim Corporation
|
6505-01-134-8387 |
Avl
|
RFQ
|
|
NDC00597 0018 61
|
dipyridamole tablet
|
Boehringer Ingelheim Corporation
|
6505-01-149-9167 |
Avl
|
RFQ
|
|
NDC00597 0018 01
|
dipyridamole tablet
|
Boehringer Ingelheim Corporation
|
6505-01-130-4669 |
Avl
|
RFQ
|
|
NDC00597-0025-04
|
mesoridazine besyla
|
Boehringer Ingelheim Corporation
|
6505-00-347-1909 |
Avl
|
RFQ
|
|
NDC00597-0068-61
|
mexiletine hydrochl
|
Boehringer Ingelheim Corporation
|
6505-01-255-9031 |
Avl
|
RFQ
|
|
3212
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3317 |
Avl
|
RFQ
|
|
NDC00597-0027-10
|
mesoridazine besyla
|
Boehringer Ingelheim Corporation
|
6505-01-146-4205 |
Avl
|
RFQ
|
|
NDC00597 0072 01
|
metaproterenol sulfate tablets usp
|
Boehringer Ingelheim Corporation
|
6505-01-010-3044 |
Avl
|
RFQ
|
|
NDC00597 0031 12
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3319 |
Avl
|
RFQ
|
|
NDC00597 0008 01
|
clonidine hydrochlo
|
Boehringer Ingelheim Corporation
|
6505-01-146-7588 |
Avl
|
RFQ
|
|
NDC00597-0049-01
|
theophylline extend
|
Boehringer Ingelheim Corporation
|
6505-01-114-4804 |
Avl
|
RFQ
|
|
0597-0006-01
|
clonidine hydrochlo
|
Boehringer Ingelheim Corporation
|
6505-01-030-1647 |
Avl
|
RFQ
|
|
NDC00597-0070-17
|
metaproterenol sulfate inhalation aerosol usp
|
Boehringer Ingelheim Corporation
|
6505-01-311-8441 |
Avl
|
RFQ
|
|
NDC00597 0007 10
|
clonidine hydrochlo
|
Boehringer Ingelheim Corporation
|
6505-01-024-9879 |
Avl
|
RFQ
|
|
NDC00597-0067-01
|
mexiletine hydrochl
|
Boehringer Ingelheim Corporation
|
6505-01-255-9028 |
Avl
|
RFQ
|
|
NDC00597-0017-01
|
dipyridamole tablet
|
Boehringer Ingelheim Corporation
|
6505-01-114-0150 |
Avl
|
RFQ
|
|
3334
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3318 |
Avl
|
RFQ
|
|
NDC00597 0070 86
|
metaproterenol sulf
|
Boehringer Ingelheim Corporation
|
6505-00-551-2295 |
Avl
|
RFQ
|
|
NDC00597 0082 18
|
ipratropium bromide
|
Boehringer Ingelheim Corporation
|
6505-01-366-8857 |
Avl
|
RFQ
|
|
NDC00597 0055 05
|
laxative kit prerad
|
Boehringer Ingelheim Corporation
|
6505-01-054-7982 |
Avl
|
RFQ
|
|
NDC00597 0069 62
|
metaproterenol sulf
|
Boehringer Ingelheim Corporation
|
6505-01-203-3389 |
Avl
|
RFQ
|
|
NDC00597 0017 10
|
dipyridamole tablet
|
Boehringer Ingelheim Corporation
|
6505-00-764-9014 |
Avl
|
RFQ
|
|
NDC00597-0006-01
|
clonidine hydrochlo
|
Boehringer Ingelheim Corporation
|
6505-01-030-1647 |
Avl
|
RFQ
|
|
NDC00597-0017-12
|
dipyridamole tablet
|
Boehringer Ingelheim Corporation
|
6505-01-147-5591 |
Avl
|
RFQ
|
|
NDC00597-0068-01
|
mexiletine hydrochl
|
Boehringer Ingelheim Corporation
|
6505-01-255-9030 |
Avl
|
RFQ
|
|
NDC00597-0032-12
|
clonidine transderm
|
Boehringer Ingelheim Corporation
|
6505-01-224-3317 |
Avl
|
RFQ
|